콘텐츠로 건너뛰기
Merck
  • Novel H3 receptor antagonists with improved pharmacokinetic profiles.

Novel H3 receptor antagonists with improved pharmacokinetic profiles.

Bioorganic & medicinal chemistry letters (2008-06-17)
Vincent J Santora, Jonathan A Covel, Rena Hayashi, Brian J Hofilena, Jason B Ibarra, Michelle D Pulley, Michael I Weinhouse, Graeme Semple, Albert Ren, Guilherme Pereira, Jeffrey E Edwards, Marissa Suarez, John Frazer, William Thomsen, Erin Hauser, Jodie Lorea, Andrew J Grottick
초록

A new series of H(3) antagonists derived from the natural product Conessine are presented. Several compounds from these new series retain the potency and selectivity of earlier diamine based analogs while exhibiting improved PK characteristics. One compound (3u) demonstrated functional antagonism of the H(3) receptor in an in vivo pharmacological model.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Conessine, ≥97% (HPLC)